Navigation Links
Drug for erectile dysfunction improves heart function in young heart-disease patients
Date:11/18/2009

Heart function significantly improved in children and young adults with single-ventricle congenital heart disease who have had the Fontan operation following treatment with sildenafil, a drug used to treat erectile dysfunction and pulmonary hypertension, say researchers from The Children's Hospital of Philadelphia.

Single-ventricle defects are a collection of cardiac malformations that impair the heart's ability to pump blood. Examples include tricuspid atresia, pulmonary atresia/intact ventricular septum and hypoplastic left heart syndrome.

The Fontan operation is a procedure that redirects systemic venous blood directly to the pulmonary arteries, bypassing the heart. It is the third surgery in a staged palliation for single-ventricle heart defects.

Researchers hypothesized that sildenafil may help cardiac performance by directly improving the squeeze of the heart muscle and by allowing for better filling of the heart.

In this study, researchers randomized 28 children and young adults who had undergone the Fontan operation to receive placebo or sildenafil three times a day for 6 weeks. After a 6-week break, subjects were switched to the opposite treatment course. The researchers found significant improvement in heart performance during treatment with sildenafil.

"The enhanced heart performance may improve exercise performance and quality of life in these children and young adults," said David J. Goldberg, M.D., pediatric cardiologist at The Children's Hospital of Philadelphia, who presented the abstract on Nov. 17 at the American Heart Association Scientific Sessions in Orlando, Fla.


'/>"/>

Contact: Joey McCool Ryan
McCool@email.chop.edu
267-426-6070
Children's Hospital of Philadelphia
Source:Eurekalert

0

GOOD

Page: 1

Related medicine news :

1. ESAI provides grant to LA BioMed to investigate long-term correction of erectile dysfunction
2. Topical Cream for Erectile Dysfunction Shows Promise
3. Enlarged Prostate and Erectile Dysfunction Are Subjects of Free Mens Health Seminar
4. Tadalafil May Effectively Treat Symptoms of BPH-LUTS in Addition to Erectile Dysfunction
5. Tadalafil may effectively treat symptoms of BPH-LUTS in addition to erectile dysfunction
6. For Erectile Dysfunction, Physicians Indicate That Opportunity Exists for Emerging Therapies with Improved Efficacy in Difficult-to-Treat Patient Subpopulations
7. Motorcycle Seats NOT The Cause of Impotence or Erectile Dysfunction for Bikers
8. Rapid Generic Erosion of Branded Agents, Including Market-Leading Viagra, Will Cause Sales of Erectile Dysfunction Drugs to Remain Flat Over the Next Decade
9. Warner Chilcott and Dong-A Sign U.S. License Agreement For Erectile Dysfunction Treatment
10. Despite Sagging Economy, Viamedic Reports Solid Online Sales for Erectile Dysfunction Drugs
11. Hispanic Men Face Elevated Risk of Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2010)... two or more soft drinks per week increased the ... with individuals who did not consume soft drinks, according ... Prevention , a journal of the American Association for ... remains one of the most deadly; only 5 percent ... , Mark Pereira, Ph.D., senior author on the study ...
(Date:2/9/2010)... Feb. 9 The following is a ... ,, "Reversing the childhood obesity epidemic will require the ... demonstrated today. ,, "As the First Lady ... with chips and soda -- and few healthy food ... bleak food landscape extends far beyond the school yard. ...
(Date:2/9/2010)... The association between television viewing and childhood obesity is ... unhealthy foods, according to a new UCLA School of ... of Public Health . , The study, conducted by ... first to break down the types of television children ... may exert different effects on obesity. , The researchers ...
(Date:2/9/2010)... with fewer complications, study finds , , TUESDAY, Feb. 9 ... more likely than men to fail catheter ablation treatments ... five times as often as women and usually have ... issue of HeartRhythm Journal , are based on ... 2008. They underwent pulmonary vein antrum isolation, a kind ...
(Date:2/9/2010)... Feb. 9 Alan Revell of ... a nursing home before he quit. What he witnessed was the ... Annandale . ,, "I just knew that there had to be ... President/CEO of Caring Rose Home Care. "What I saw in just ... respectable nursing homes, but I knew right then that we needed ...
Breaking Medicine News(10 mins):Health News:Soft drinks may increase risk of pancreatic cancer 2Health News:Childhood obesity: It's not the amount of TV, it's the number of junk food commercials 2Health News:Caring Rose Home Care Launched To Help Seniors Live Independently 2
... Cambrex,Corporation (NYSE: CBM ) announced that it will release third quarter ... http://www.newscom.com/cgi-bin/prnh/20000613/CAMBREXLOGO ) The Company will host a conference call to discuss ... Third Quarter 2007 ... Friday, November 2, 2007 at 8:30 a.m. Eastern Time, ...
... Mapping and Magnetic Guidewire Navigation ... Capabilities Demonstrated in Multiple Cases, ST. LOUIS, Oct. ... of successful, live percutaneous coronary,and peripheral cases performed with ... Arena at the Transcatheter Cardiovascular,Therapeutics (TCT) symposium, held this ...
... PAUL, Minn. and PRINCETON, N.J., Oct. 25 ... Corporate Research (NYSE: SI ),and a majority-owned ... today,announced an exclusive multi-year marketing agreement involving Zargis,heart ... Under the agreement, Zargis will support 3M ...
... 25 The USO has,partnered with CarePages.com to provide ... their families and friends while recovering,in the hospital and ... families communicate by sharing health updates, photos and supportive,messages ... to military families,needing care and support, and allows them ...
... conduct Continuing Medical Education, Body Mass Index training events for physicians ... ... Morgantown, CHARLESTON, W.Va., Oct. 25 With adult and childhood,obesity ... to be an innovator for solutions.,UniCare will announce later today that the ...
... SAN FRANCISCO What are the cancer drugs ... Today, at the AACR-NCI-EORTC International Conference on Molecular ... answers to these and other pressing questions regarding ... such as cell signaling receptors found on cancer ...
Other Medicine News:Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 2Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 3Health News:Stereotaxis Highlights Live Coronary and Peripheral Vascular Cases Performed at TCT With Stereotaxis Magnetic Navigation System 4Health News:3M and Zargis Announce Global Marketing Alliance 2Health News:3M and Zargis Announce Global Marketing Alliance 3Health News:3M and Zargis Announce Global Marketing Alliance 4Health News:The USO and CarePages.com Help Wounded Troops Stay Connected to Their Families 2Health News:The USO and CarePages.com Help Wounded Troops Stay Connected to Their Families 3Health News:State's Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic 2Health News:State's Largest Medicaid Managed Care Plan Offering Training to Combat West Virginia Obesity Epidemic 3Health News:Targets on the horizon: Emerging therapies and novel targets 2Health News:Targets on the horizon: Emerging therapies and novel targets 3Health News:Targets on the horizon: Emerging therapies and novel targets 4Health News:Targets on the horizon: Emerging therapies and novel targets 5Health News:Targets on the horizon: Emerging therapies and novel targets 6Health News:Targets on the horizon: Emerging therapies and novel targets 7
(Date:2/8/2010)... ST. LOUIS , Feb. 8 ... Allied Healthcare Products (Nasdaq: AHPI ) narrowly back ... 2010. ,, Sales for the quarter ended December ... $12.5 million during the same quarter last ... quarter. However, Allied,s costs of sales were reduced even ...
(Date:2/8/2010)... FRANKLIN LAKES, N.J. , Feb. 8 /PRNewswire/ ... and Company), announced today the launch of BD Microtainer® ... new product is designed to improve the safety, accuracy ... in patients with veins that can be difficult to ... elderly. The new BD Microtainer MAP product is also ...
(Date:2/8/2010)... Transgenomic, Inc. (OTC Bulletin Board: TBIO) ... study with a leading pharmaceutical company that validates ... detect colorectal tumor-associated KRAS mutations that determine efficacy ... plasma samples in which the mutation levels were ... methodologies such as Sanger sequencing. ,, The study, ...
Breaking Medicine Technology:Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6BD Launches New Device Designed to Improve Safety, Accuracy and Turnaround Time of Blood Collection in Patients with Fragile Veins 2Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 2Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 3Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR 4The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 1The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 2The San Francisco SPCA Launches Online Guide for Summer Pet Health 26 Safety 53233 3Governor Eliminates Funding to Domestic Violence Programs 53230 1Governor Eliminates Funding to Domestic Violence Programs 53230 2Metabolife 28R 29 Reminds Us That the Little Things We Do Can Bring Positive Change to Our Lives and the Lives of Others 53228 1Metabolife 28R 29 Reminds Us That the Little Things We Do Can Bring Positive Change to Our Lives and the Lives of Others 53228 2
... DIEGO, March 9 Cardium Therapeutics (NYSE Alternext ... Inc., today reported that positive clinical findings demonstrating ... cooling techniques during robotic-assisted radical prostatectomy surgery will ... Urology and is now available online ...
... dosed every two weeks met the primary efficacy ... alfa-2a dosed weekly in patients with genotype 1 ... Albuferon had comparable rates of serious and/or severe ... global marketing applications planned in fall 2009 -ROCKVILLE, ...
Other Medicine Technology:Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 2Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 3Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 4Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 5Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 6Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 7Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 2Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 3Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 4Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 5Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 6Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 7Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 8Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 9Human Genome Sciences Announces Positive Results in Second of Two Phase 3 Trials of Albuferon(R) in Chronic Hepatitis C 10
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: